MRC1 and neoplasm: Decreased neutrophil infiltration and reduced expression of the immunosuppressive macrophage marker CD206 upon zotatifin treatment were consistently observed across multiple mouse models, as analyzed by flow cytometry (Figure 2, E and F), indicating a general effect of zotatifin on the tumor immune microenvironment.